The trial was the first to assess R-MDMA in patients with social anxiety disorder, AtaiBeckley CEO Srinivas Rao said in a statement.
- Home |
- Analysts see potential in MDMA drug after AtaiBeckley reports improvements in anxiety trial
Analysts see potential in MDMA drug after AtaiBeckley reports improvements in anxiety trial
- February 26, 2026
Recent Posts
- LNG market tightens into winter as Europe pulls US cargoes, China reopens contract talks
- EIA: US crude oil inventories down 3.2 million bbl
- Chevron restructures Bakken midstream agreements, transfers Hess Midstream stake
- Cenovus to build oil sands business via Athabasca acquisition
- Centalion acquires Haynesville gas assets from Silver Hill
